LIVN — LivaNova PLC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1639691 ·
United Kingdom
Last close
$76.63
Market Cap
$4.21B
52W High
$85.76
52W Low
$48.82
ADV30
621,020
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 390,587,000 | 273,670,000 | 49,484,000 | 108,569,000 | 2,640,861,000 | 516,619,000 | 1,315,539,000 |
| Mar 2026 | 362,258,000 | 243,749,000 | 41,471,000 | 22,294,000 | 2,516,351,000 | 539,706,000 | 1,305,025,000 |
| Dec 2025 | 360,921,000 | 239,773,000 | 42,578,000 | 30,906,000 | 2,606,053,000 | 635,552,000 | 1,406,066,000 |
| Sep 2025 | 357,753,000 | 244,855,000 | 54,012,000 | 26,784,000 | 2,557,583,000 | 646,079,000 | 1,400,353,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$245,590,000
Investing CF
$-76,864,000
Financing CF
$-375,484,000
CapEx
$-84,550,000
Dividends Paid
—
Buybacks
$-368,000
EPS Diluted TTM
$1.95
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,014,858,000
Inventory
$172,612,000
Receivables
$274,173,000
ST Investments
—
EBIT TTM
$144,696,000
Pretax Income TTM
$107,509,000
Interest Exp TTM
$37,187,000
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,471,518,976
EBITDA
$260,138,000
Free Cash Flow
$59,872,624
Enterprise Value
$4,142,540,288
Total Cash
$516,619,008
Total Debt
$351,948,992
Shares Out
54,933,538
Trailing EPS
$3.39
Book Value
$24.07
ROE
15.4%
ROA
5.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,388,053,000 | 199,390,000 | -242,471,000 | 2,606,053,000 | 1,406,066,000 | 1,199,987,000 | 254,340,000 |
| Dec 2024 | 1,253,437,000 | 129,051,000 | 63,234,000 | 2,506,389,000 | 1,186,131,000 | 1,320,258,000 | 183,038,000 |
| Dec 2023 | 1,153,545,000 | 21,476,000 | 17,546,000 | 2,429,563,000 | 1,151,935,000 | 1,277,628,000 | 74,914,000 |
| Dec 2022 | 1,021,805,000 | 52,644,000 | -86,246,000 | 2,294,773,000 | 1,087,149,000 | 1,207,624,000 | 69,921,000 |
TTM Snapshot
Revenues TTM
$1,173,693,000
NetIncome TTM
$-409,031,000
OpCashFlow TTM
$0
Assets (Latest)
$2,606,053,000
Forward EPS
$4.68
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $77.50 · spot: $76.64 · call volume: 83 · put volume: 27
Expected Move to 2027-01-15:
±$12.50
(16.31%) —
implied range
$64.14 –
$89.14
· ATM straddle on $77.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HTFL | Heartflow, Inc. | $4.28B | $49.17 | — |
| ITGR | Integer Holdings Corp | $4.29B | $126.34 | — |
| ICUI | ICU MEDICAL INC/DE | $4.12B | $164.95 | — |
| NVST | Envista Holdings Corp | $3.85B | $23.95 | — |
| HAE | HAEMONETICS CORP | $4.79B | $105.30 | — |
News headlines (Yahoo Finance, 1h cache)
LivaNova to Announce Third-Quarter 2026 Results
2026-09-23 13:00 · Yahoo
LivaNova Director Sells 1,650 Shares for $131,500
2026-09-11 01:15 · Yahoo
GHO Capital appoints Vivid Sehgal as Operating Partner
2026-09-08 08:00 · Yahoo
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September
2026-09-03 13:00 · Yahoo
LivaNova (LIVN) Q2 2026 Earnings Call Transcript
2026-08-12 15:34 · Yahoo
LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised
2026-08-06 16:31 · Yahoo
LivaNova Q2 Earnings Call Highlights
2026-08-05 17:04 · Yahoo
LivaNova PLC Q2 2026 Earnings Call Summary
2026-08-05 22:03 · Yahoo
Operating Leverage and Product Innovation Drive LivaNova’s(LIVN) Sustained Profit Outlook
2026-09-24 13:50 · Yahoo
NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth
2026-08-17 17:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.